Contraceptives, Oral
Research News and Information

Sunday, November 22, 2009

Attitudes toward menstrual suppression and conformity to feminine norms in young and middle-aged Mexican women.

30 Aug 2009 Seventy seven college students and 66 middle-aged Mexican women completed an adapted questionnaire of attitudes toward menstrual suppression and the Conformity to Feminine Norms Inventory. Participants showed a great interest in menstrual ... Read more...

Oral contraceptives and neoplasms other than breast and female genital tract.

30 Aug 2009 We reviewed epidemiological data on oral contraceptive (OC) use and colorectal, liver, lung and other nonfemale neoplasms. The data for colorectal cancer are suggestive of a favourable effect of OC, in the absence, however, of any duration-risk ... Read more...

The epidemiology of ovarian granulosa cell tumors: a case-control study.

5 Aug 2009 OBJECTIVE: This study identified risk factors for ovarian granulosa cell tumors (GCT) through a case-control study comparing women with GCT to women with epithelial ovarian cancers (OC) and general population (GP) controls. METHODS: Women with GCT ... Read more...

Latest indexed articles for 'Contraceptives, Oral'

These are the very latest articles for this heading:

• Oral contraceptives and venous thromboembolism: old questions revisited. 29 Sep 2009
• Treating premenstrual dysphoric disorder. Options include drugs targeting serotonin and various types of hormone therapy. 29 Sep 2009
• Attitudes toward menstrual suppression and conformity to feminine norms in young and middle-aged Mexican women. 30 Aug 2009
• Discussion: 'Factors influencing oral contraceptive effectiveness' by Dinger et al. 30 Aug 2009
• Oral contraceptives and neoplasms other than breast and female genital tract. 30 Aug 2009
• Hirsutism. 26 Aug 2009
• Parity and subfertility effects of continuous oral contraceptive on fertility are important. 20 Aug 2009
• Re: "a case-control study of oral contraceptive use and incident breast cancer". 9 Aug 2009
• The epidemiology of ovarian granulosa cell tumors: a case-control study. 5 Aug 2009
• Reproductive factors, exogenous estrogen use, and risk of Parkinson's disease. 13 Jul 2009
• Maternal use of oral contraceptives during early pregnancy and risk of hypospadias in male offspring. 7 Jul 2009
• [Oral contraceptives in dermatology] 29 Jun 2009
• Genetic counseling for teratogenic risk due to exposure to medications: 89 pregnancies conceived during oral contraceptive use. 29 Jun 2009
• Diffusion weighted imaging of the uterus: regional ADC variation with oral contraceptive usage and comparison with cervical cancer. 29 Jun 2009
• Oral contraceptive use and BRCA penetrance: a case-only study. 21 Jun 2009
• Moving beyond dichotomies in research on oral contraceptives: a comment on Edwards and O'Neal. 10 Jun 2009
• Hormonal contraceptive regimens in the perimenopause. 10 Jun 2009
• [Influence of premenstrual syndrome and oral contraceptive effects on food choice during the follicular and luteal phase of the menstrual cycle] 9 Jun 2009
• Oral contraceptives and family history of breast cancer. 8 Jun 2009
• ADAMTS13 in health and disease. 6 Jun 2009

See a longer list of these articles.

Technical information about 'Contraceptives, Oral'

Definition: Compounds, usually hormonal, taken orally in order to block ovulation and prevent the occurrence of pregnancy. The hormones are generally estrogen or progesterone or both.

Registry Number: 0

Descriptor UI: D003276

Alternative terms: Contraceptives, Oral; Oral Contraceptives; Oral Contraceptives, Phasic; Contraceptives, Phasic Oral; Phasic Oral Contraceptives; Oral Contraceptives, Low-Dose; Contraceptives, Low-Dose Oral; Low-Dose Oral Contraceptives; Oral Contraceptives, Low Dose;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.505.696.875.360.276.210; D27.505.954.705.360.276.210;

Technical Notes: pregn despite use: see note on CONTRACEPTIVE AGENTS